Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
EDITOR,--J E Compston and colleagues review the indications for bone densitometry in clinical practice.1 They agree with the conclusions of the Effective Health Care bulletin that there is insufficient evidence to justify screening women at the menopause.2 Several of their other recommendations, however, do not seem to be supported by the evidence.
The authors propose that bone densitometry should be used, for example, for people with strong clinical risk factors. This is justified only if the information provided by the test can influence decision making in a way that improves the effectiveness or cost effectiveness of treatment.3 However, no evidence is cited to show that decision making is improved as a result of bone densitometry in people at increased risk of fracture due to accelerated bone loss. Since the presence of multiple risk factors is more important than the result of bone
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?